OXURION (EBR:OXUR) | WebDisclosure

Basculer en Français

9810	Companies
196811	Keywords
127805	Articles
104627	Press releases

Home
Companies
OXURION

PRESS RELEASE

published on 07/17/2025 at 08:30, 6 months 19 days ago

Oxurion Secures Financing for the Acquisition of Axiodis CRO and Targets Closing on August 1, 2025
Oxurion NV secures financing for 72% stake in Axiodis CRO, enhancing its clinical data capabilities. Acquisition aligned with strategic roadmap for European hub. Closing set for August 1, 2025

Acquisition Clinical Data Oxurion NV Axiodis CRO European Hub
PRESS RELEASE

published on 07/17/2025 at 08:30, 6 months 19 days ago

Oxurion verzekert financiering voor de overname van Axiodis CRO en beoogt een closing op 1 augustus 2025
Oxurion sichert Finanzierung für die Übernahme von Axiodis CRO ab und plant Abschluss der Transaktion am 1. August 2025

Übernahme Finanzierung Oxurion Klinische Daten Therapeutische Entwicklung
BRIEF

published on 07/15/2025 at 18:05, 6 months 20 days ago

Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC

Shares Transparency Atlas Biopharmaceutical Oxurion
BRIEF

published on 07/15/2025 at 18:05, 6 months 20 days ago

Oxurion reçoit une notification de transparence d'Atlas Special Opportunities II LLC

Actions Atlas Transparence Biopharmaceutique Oxurion
PRESS RELEASE

published on 07/15/2025 at 18:00, 6 months 20 days ago

Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC
Oxurion NV receives transparency notification from Atlas Special Opportunities II, LLC regarding shareholding threshold crossing under Belgian Transparency legislation

Transparency Notification Shareholding Oxurion NV Belgian Legislation Atlas Special Opportunities II LLC
PRESS RELEASE

published on 07/15/2025 at 18:00, 6 months 20 days ago

Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC
Oxurion NV meldt ontvangst van transparantiekennisgeving en verlaagd aandelenposities onder wettelijke drempel. Biofarmaceutisch bedrijf in Leuven actief op gebied van therapeutische innovatie en klinisch onderzoek

Transparantiekennisgeving Euronext Brussel Oxurion NV Leuven Biofarmaceutisch
BRIEF

published on 07/14/2025 at 18:05, 6 months 21 days ago

Oxurion Announces Transparency Notifications from Atlas

Biopharmaceutical Shareholder Notification Atlas Special Opportunities Oxurion NV Transparency Legislation
BRIEF

published on 07/14/2025 at 18:05, 6 months 21 days ago

Oxurion annonce les notifications de transparence d'Atlas

Biopharmaceutique Notification Aux Actionnaires Oxurion NV Opportunités Spéciales Atlas Législation Sur La Transparence
PRESS RELEASE

published on 07/14/2025 at 18:00, 6 months 21 days ago

Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC
Oxurion NV receives transparency notifications regarding changes in shareholding from Atlas Special Opportunities II, LLC, in accordance with Belgian Transparency legislation

Shareholding Oxurion NV Belgian Legislation Transparency Notifications Atlas Special Opportunities II LLC
PRESS RELEASE

published on 07/14/2025 at 18:00, 6 months 21 days ago

Oxurion ontvangt transparantiekennisgevingen van Atlas Special Opportunities II LLC
Oxurion NV heeft transparantiekennisgevingen ontvangen volgens de Belgische wetgeving betreffende belangrijke deelnemingen. Atlas Special Opportunities II LLC heeft aanzienlijke aandelen in Oxurion verworven en verkocht. Raadpleeg www.oxurion.com voor meer informatie

Transparantiekennisgevingen Oxurion NV Biofarmaceutisch Belgische Wetgeving Atlas Special Opportunities II LLC

Accesswire

Published on 02/05/2026 at 14:50, 14 minutes ago

High Tide Resources Announces Non-Brokered Private Placements
Published on 02/05/2026 at 14:30, 34 minutes ago

Electrovaya Announces Date for Q1-2026 Financial Results & Conference Call
Published on 02/05/2026 at 14:30, 34 minutes ago

Innodata to Report Fourth Quarter and Fiscal Year 2025 Results
Published on 02/05/2026 at 14:00, 1 hour 4 minutes ago

Organto Foods Inc. Expects Strong 2026 Growth Driven by Retail Wins and Expanded Supply Partnerships
Published on 02/05/2026 at 14:00, 1 hour 4 minutes ago

Tectonic Metals Drills 272 Metres of 0.50 g/t Au and 277 Metres of 0.49 g/t Au; Confirms Bulk-Tonnage Potential at Heap-Leachable Chicken Mountain, Flat Gold Project, Alaska

View all ACCESSWIRE

EQS Group

Published on 02/05/2026 at 14:43, 20 minutes ago

Turkiye Garanti Bankasi A.S.: BRSA Consolidated Earnings Presentation dated 31 December 2025
Published on 02/05/2026 at 14:40, 24 minutes ago

NITECORE Sets a New Standard for Ultralight Power: the New 143g, IPX7-Rated NB10000 Gen4
Published on 02/05/2026 at 14:35, 29 minutes ago

DLG Launches LuxuryIQ MCP: The Luxury Industry's First AI Data Integration Layer
Published on 02/05/2026 at 14:10, 54 minutes ago

Ocean Tomo Bolsters Radio Frequency, Wireless, and Spectrum Expertise with Addition of Director Dan Sleeter
Published on 02/05/2026 at 14:00, 1 hour 4 minutes ago

Gurit Expands U.S. Operations to Support Growing Subsea Demand

Les Echos

Published on 02/05/2026 at 11:30, 3 hours 34 minutes ago

Déclaration nombre d'actions et droits de vote - 05.02.2026
Published on 02/05/2026 at 11:30, 3 hours 34 minutes ago

Disclosure of shares outstanding and voting rights - 05.02.2026
Published on 02/04/2026 at 18:04, 21 hours ago

Capital et droits de vote au 31 janvier 2026
Published on 02/04/2026 at 18:04, 21 hours ago

Total number of voting rights and shares making up the share capital at January 31, 2026
Published on 02/04/2026 at 17:45, 21 hours 19 minutes ago

Information concerning the total number of voting rights and shares 2026 01 31

View all LES ECHOS COMFI WIRE